• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Neurobiological Technologies Inc

+ Add to Watchlist


0.0300 USD 0.00000.00%

As of 20:10:01 ET on 12/19/2014.

Snapshot for Neurobiological Technologies Inc (NTII)

Open: 0.0300 Day's Range: 0.0300 - 0.0300 Volume: 142
Previous Close: 0.0300 52wk Range: 0.0150 - 0.0900 1-Yr Rtn: -66.67%

Stock Chart for NTII

No chart data available.
  • NTII:US 0.0300
  • 1D
  • 1M
  • 1Y
Interactive NTII Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NTII

Current P/E Ratio (ttm) 0.0405
Estimated P/E(06/2010) -
Relative P/E vs. SPX 0.0022
Earnings Per Share (USD) (ttm) 0.7400
Est. EPS (USD) (06/2010) -
Est. PEG Ratio -
Market Cap (M USD) 0.81
Shares Outstanding (M) 27.02
30 Day Average Volume 2,667
Price/Book (mrq) 0.0348
Price/Sale (ttm) 0.0319
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 0.0500
Dividend Ex-Date 12/18/2012
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NTII

No data available

Company Profile & Key Executives for NTII

Neurobiological Technologies, Inc. (NTI) is a biopharmaceutical company focused on the clinical development and regulatory approval of neuroscience drugs. NTI is developing neuroprotective and neuromodulatory agents to treat progressive neurological impairments characteristic of various nervous system disorders, including diabetic neuropathy, brain cancer, and AIDS dementia syndrome.

Matthew M LoarActing CEO/Acting CFO
More Company Profile & Key Executives for NTII

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil